Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FY8PH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,357
Award facts
- Contract value 100% obligated
- $12,357.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,357.44 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3ml vials. This is a firm fixed-price, non-set-aside contract with a completion date of December 22, 2025, issued on December 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and established federal vendor serving military and veteran healthcare systems. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract vehicle extending through December 2026 that provides comprehensive pharmaceutical and medical supply support to defense health programs globally.
This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's master contract with DLA, enabling the supply of diabetes medications and other critical pharmaceuticals to support military healthcare operations. As a child contract under the larger IDC, this order demonstrates the vendor's ongoing role as a primary pharmaceutical supplier for federal medical procurement needs. The firm fixed-price structure and competitive award history indicate AmerisourceBergen's established capability to meet DLA's exacting procurement standards for medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FY8PH?
SPE2DR26FY8PH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FY8PH worth?
The government has obligated $12,357 on SPE2DR26FY8PH.
Is contract SPE2DR26FY8PH an order under another contract?
Yes. SPE2DR26FY8PH is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8PH competed?
The extent of competition for SPE2DR26FY8PH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award